Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency [Phase 3]
Phase 3 trial assessing the effects of growth hormone on cognition and cerebral metabolism in adults with growth hormone deficiency due to h…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children [Phase 3]
A Phase 3 study comparing three-times-weekly versus daily growth hormone in treatment-naïve children with growth hormone deficiency has comp…
-
CLINICAL_TRIALS research · 2017-10-12Clinical Trial Update: Observational Prospective Study on Patients Treated With Norditropin®
An observational prospective study assesses outcomes in patients treated with Norditropin (somatropin) for growth hormone-related disorders.
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9 [Phase 2]
A Phase 2 clinical study evaluating GX-H9 for safety, tolerability, and efficacy in adults with growth hormone deficiency has completed.
-
CLINICAL_TRIALS research · 2017-08-15Clinical Trial Update: Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency [Phase 4]
Phase 4 clinical trial update for Pegylated Somatropin in children with Growth Hormone Deficiency; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children [Phase 3]
Phase III clinical trial evaluating pegylated somatropin for growth hormone deficiency in children has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children [Phase 2]
Phase 2 clinical trial assessing the efficiency and safety of a pegylated form of somatropin for treating growth hormone deficiency in child…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Role of Nutrition and Hormones in Boys With Disordered Growth [Phase 2]
Phase 2 clinical trial assessing how nutrition and hormones influence growth in boys with disordered growth; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Adrenal Function in GHD Children
A completed clinical trial update examining adrenal function in children with growth hormone deficiency receiving growth hormone treatment.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency [Phase 4]
Clinical trial update on Pegylated Somatropin for treating children with Growth Hormone Deficiency in a Phase 4 study.
-
CLINICAL_TRIALS research · 2017-06-16Clinical Trial Update: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I) [Phase 4]
Phase IV clinical study investigating pegylated somatropin for children with growth hormone deficiency; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency [Phase 4]
Update on a Phase 4 clinical trial evaluating pegylated somatropin for treatment of growth hormone deficiency in children.
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON
An online surveillance study has completed, monitoring outcomes in children with growth hormone deficiency treated with ZOMACTON (somatropin…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: National Cooperative Growth Study in CKD
The National Cooperative Growth Study in CKD has completed. It is sponsored by the University of California, Davis and concerns growth hormo…
-
FDA label_change · 2017-05-24FDA Approved: SEROSTIM — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for SEROSTIM (somatropin) from EMD Serono, Inc. to update the product labeling. The changes expand o…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: rhGH Therapy on Hepatic Drug Metabolism
A completed clinical trial evaluating the effect of recombinant human growth hormone therapy on hepatic drug metabolism.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: 304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency [NA]
A clinical trial entry describing a study on the effects of growth hormone on glucose and protein metabolism in children with growth hormone…
-
CLINICAL_TRIALS research · 2017-04-12Clinical Trial Update: An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
An observational registry assessing real-world outcomes and safety of Norditropin (somatropin) in children and adults treated for growth hor…
-
CLINICAL_TRIALS research · 2017-04-07Clinical Trial Update: A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD [Phase 2]
A non-inferiority Phase 2 trial is evaluating the safety and efficacy of PEG-rhGH for adult growth hormone deficiency. The study status is u…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis [NA]
The clinical trial evaluated the glucagon stimulation test for diagnosing adult growth hormone deficiency and assessing the adrenocorticotro…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD) [Phase 4]
An open-label Phase 4 trial assessing the immunogenicity of the liquid formulation of Saizen in adults with Adult Growth Hormone Deficiency;…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Single Low-Dose of Supplement Amino Acid [NA]
A completed clinical trial evaluated a single low-dose amino acid supplement with results posted in 2017, investigating effects related to g…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency [Phase 2]
Phase 2 safety, pharmacokinetic and pharmacodynamic study of TransCon hGH (ACP-001) in adults with growth hormone deficiency has completed w…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency [Phase 3]
A Phase 3 study assessing the safety and efficacy of somatropin in children with growth hormone deficiency has been completed. The sponsor i…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) [Phase 3]
A completed Phase 3 long-term trial evaluating growth hormone deficiency in adults (GHDA) sponsored by Novo Nordisk.